APRIL CAR T cells (AUTO2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APRIL CAR T cells (AUTO2), covering 2020-10-23 to 2020-10-23. Get the full timeline:
Most recent: Clinical Trial Update: APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma [Phase 1, Phase 2]